Company Name:PTC Therapeutics Inc.
CEO: Stuart W. Peltz

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.


Key numbers

Market Capitalization:2537964580
Shares Outstanding: 61631000
Float: 59457459.522999994
Next Earning Date:2020-03-04
TTm EPS: -4.0613
TTm Dividend Rate:
200 days moving average:39.1
50 days moving average: 38.65
One day percent Change: 2.36



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,